420 related articles for article (PubMed ID: 33321259)
1. Mass spectrometry-based proteomics analyses of post-translational modifications and proteoforms in human pituitary adenomas.
Li J; Zhan X
Biochim Biophys Acta Proteins Proteom; 2021 Mar; 1869(3):140584. PubMed ID: 33321259
[TBL] [Abstract][Full Text] [Related]
2. Human growth hormone proteoform pattern changes in pituitary adenomas: Potential biomarkers for 3P medical approaches.
Li B; Wang X; Yang C; Wen S; Li J; Li N; Long Y; Mu Y; Liu J; Liu Q; Li X; Desiderio DM; Zhan X
EPMA J; 2021 Mar; 12(1):67-89. PubMed ID: 33786091
[TBL] [Abstract][Full Text] [Related]
3. MASS SPECTROMETRY-BASED MITOCHONDRIAL PROTEOMICS IN HUMAN OVARIAN CANCERS.
Li N; Zhan X
Mass Spectrom Rev; 2020 Sep; 39(5-6):471-498. PubMed ID: 32020673
[TBL] [Abstract][Full Text] [Related]
4. Comparative proteomics analysis of human pituitary adenomas: current status and future perspectives.
Zhan X; Desiderio DM
Mass Spectrom Rev; 2005; 24(6):783-813. PubMed ID: 15495141
[TBL] [Abstract][Full Text] [Related]
5. Human Pituitary Adenoma Proteomics: New Progresses and Perspectives.
Zhan X; Wang X; Cheng T
Front Endocrinol (Lausanne); 2016; 7():54. PubMed ID: 27303365
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in proteomics and its implications in pituitary endocrine disorders.
Banerjee A; Goel A; Shah A; Srivastava S
Biochim Biophys Acta Proteins Proteom; 2021 Nov; 1869(11):140700. PubMed ID: 34303023
[TBL] [Abstract][Full Text] [Related]
7. The use of mass spectrometry in a proteome-centered multiomics study of human pituitary adenomas.
Li N; Desiderio DM; Zhan X
Mass Spectrom Rev; 2022 Nov; 41(6):964-1013. PubMed ID: 34109661
[TBL] [Abstract][Full Text] [Related]
8. Constructing Human Proteoform Families Using Intact-Mass and Top-Down Proteomics with a Multi-Protease Global Post-Translational Modification Discovery Database.
Dai Y; Buxton KE; Schaffer LV; Miller RM; Millikin RJ; Scalf M; Frey BL; Shortreed MR; Smith LM
J Proteome Res; 2019 Oct; 18(10):3671-3680. PubMed ID: 31479276
[TBL] [Abstract][Full Text] [Related]
9. Analysis of cardiac troponin proteoforms by top-down mass spectrometry.
Tiambeng TN; Tucholski T; Wu Z; Zhu Y; Mitchell SD; Roberts DS; Jin Y; Ge Y
Methods Enzymol; 2019; 626():347-374. PubMed ID: 31606082
[TBL] [Abstract][Full Text] [Related]
10. Advances in enrichment methods for mass spectrometry-based proteomics analysis of post-translational modifications.
Brandi J; Noberini R; Bonaldi T; Cecconi D
J Chromatogr A; 2022 Aug; 1678():463352. PubMed ID: 35896048
[TBL] [Abstract][Full Text] [Related]
11. Improving Proteoform Identifications in Complex Systems Through Integration of Bottom-Up and Top-Down Data.
Schaffer LV; Millikin RJ; Shortreed MR; Scalf M; Smith LM
J Proteome Res; 2020 Aug; 19(8):3510-3517. PubMed ID: 32584579
[TBL] [Abstract][Full Text] [Related]
12. Identification, Quantification, and Site Localization of Protein Posttranslational Modifications via Mass Spectrometry-Based Proteomics.
Ke M; Shen H; Wang L; Luo S; Lin L; Yang J; Tian R
Adv Exp Med Biol; 2016; 919():345-382. PubMed ID: 27975226
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Proteoform Post-Translational Modifications by Top-Down and Bottom-Up Mass Spectrometry in Conjunction with Annotations.
Chen W; Ding Z; Zang Y; Liu X
J Proteome Res; 2023 Oct; 22(10):3178-3189. PubMed ID: 37728997
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Proteoforms with Unknown Post-translational Modifications Using the MIScore.
Kou Q; Zhu B; Wu S; Ansong C; Tolić N; Paša-Tolić L; Liu X
J Proteome Res; 2016 Aug; 15(8):2422-32. PubMed ID: 27291504
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Human Sperm Protamine Proteoforms through a Combination of Top-Down and Bottom-Up Mass Spectrometry Approaches.
Soler-Ventura A; Gay M; Jodar M; Vilanova M; Castillo J; Arauz-Garofalo G; Villarreal L; Ballescà JL; Vilaseca M; Oliva R
J Proteome Res; 2020 Jan; 19(1):221-237. PubMed ID: 31703166
[TBL] [Abstract][Full Text] [Related]
16. Protein Post-Translational Modification Crosstalk in Acute Myeloid Leukemia Calls for Action.
Hernandez-Valladares M; Wangen R; Berven FS; Guldbrandsen A
Curr Med Chem; 2019; 26(28):5317-5337. PubMed ID: 31241430
[TBL] [Abstract][Full Text] [Related]
17. Mass spectrometric analysis of post-translational modifications (PTMs) and protein-protein interactions (PPIs).
Ngounou Wetie AG; Woods AG; Darie CC
Adv Exp Med Biol; 2014; 806():205-35. PubMed ID: 24952184
[TBL] [Abstract][Full Text] [Related]
18. Elucidating Escherichia coli Proteoform Families Using Intact-Mass Proteomics and a Global PTM Discovery Database.
Dai Y; Shortreed MR; Scalf M; Frey BL; Cesnik AJ; Solntsev S; Schaffer LV; Smith LM
J Proteome Res; 2017 Nov; 16(11):4156-4165. PubMed ID: 28968100
[TBL] [Abstract][Full Text] [Related]
19. Characterizing disease-associated changes in post-translational modifications by mass spectrometry.
Thygesen C; Boll I; Finsen B; Modzel M; Larsen MR
Expert Rev Proteomics; 2018 Mar; 15(3):245-258. PubMed ID: 29376447
[TBL] [Abstract][Full Text] [Related]
20. Deep Intact Proteoform Characterization in Human Cell Lysate Using High-pH and Low-pH Reversed-Phase Liquid Chromatography.
Yu D; Wang Z; Cupp-Sutton KA; Liu X; Wu S
J Am Soc Mass Spectrom; 2019 Dec; 30(12):2502-2513. PubMed ID: 31755044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
